News
Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.
Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...
Dr. Deano Reyes, an LGBTQ+ health doctor and the medical director of Hara Clinic, and Ico Johnson, the vice president of HIV ...
The Coastal Bend Wellness Foundation could soon have to scale back their HIV and STI screening due to recent federal funding ...
Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...
The Partnership for Public Service has put on the Service to America medals for more than two decades to recognize ...
As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...
Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s ...
SCHD Director-Health Officer Dr. Michelle Taylor said that the infection rate for people between the ages of 15 and 19 in ...
The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.
SCHD Director-Health Officer Dr. Michelle Taylor said that the infection rate for people between the ages of 15 and 19 in ...
In a vital effort toward cancer prevention and adolescent health equity, 14 young people living with HIV were vaccinated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results